Polyclonal Ki-67 expression in transitional cell carcinoma of the bladder

Pathology

Volumn 29, Issue 1, 1997, Pages 84-87

  Jones, Heledd L ^a   Delahunt, Brett ^a   Bethwaite, Peter B ^a   Thornton, Ann ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Bladder carcinoma; Immunohistochemistry; Ki 67; Polyclonal antibody; Proliferation kinetics; Transitional cell carcinoma; Tumor grade; Tumor stage

Indexed keywords

POLYCLONAL ANTIBODY;

ARTICLE; BLADDER CARCINOMA; CANCER INVASION; CARCINOMA IN SITU; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH;

EID: 0030960518     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029700169614     Document Type: Article

References (22)

1. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
2. Verheijen R, Kuijpers HJH, Schlingemann RO et al. Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase. J Cell Sci 1989; 92: 123-30.
3. Verheijen R, Kuijpers HJH, van Driel R et al. Ki-67 detects a nuclear matrix-associated proliferation-related antigen II. Localization in mitotic cells and association with chromosomes. J Cell Sci 1989; 92: 531-40.
4. Fontana D, Bellina M, Gubetta G et al. Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J Urol 1992; 148: 1149-51.
5. Limas C, Bigler A, Bair R, Bernhart P, Reddy P. Proliferfation activity of urothelial neoplasms: comparison of BrdU incorporation, Ki-67 expression and nucleolar organiser regions. J Clin Pathol 1993; 46: 159-65.
6. Hall PA, Woods A. Immunohistochemical markers of cell proliferation: achievements, problems and prospects. Cell Tissue Kinetics 1990; 23: 531-49.
7. Key G, Larson Petersen J, Becker MHG et al. New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections. J Clin Pathol 1993; 46: 1080-4.
8. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumors. International histological classification of tumor No. 10. Geneva: WHO. 1973.
9. Harmen MH, editor. TNM Classification of Malignant Tumors. Geneva: Union Internationale Contre le Cancer, 1978.
10. Delahunt B, Nacey JN. Renal cell carcinoma: histological indicators of prognosis. Pathology 1987; 19: 258-63.
11. Tsujihashi H, Nakanishi A, Matsuda H, Uejima S, Kurita T. Cell proliferation of human bladder tumors determined in BrdU and Ki-67 immunostaining. J Urol 1991; 145: 846-9.
12. Bush C, Price P, Norton J et al. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br J Cancer 1991; 64: 357-60.
13. Mulder AH, van Hootegem JC, Slyvester R et al. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle related nuclear antigen (Ki-67). J Pathol 1992; 166: 37-43.
14. Okamura K, Miyake K, Koshikawa T, Asai J. Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67. J Urol 1990; 144: 875-8.
15. Stavropoulos NE, loackim-Velogianni E, Hastazeris K et al. Growth fractions in bladder cancer defined by Ki-67: association with cancer grade, category and recurrence rate of superficial lesions. Brit J Urol 1993; 72: 736-9.
16. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB-1. Histopathology 1993; 22: 355-60.
17. Pich A, Chiusa L, Comino A, Navone R. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinoma. Virchow Arch 1994; 424: 143-8.
18. Mazerolles C, Rishmann P, Chopin D et al. Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparisons with Ki-67 antibody. Histopathology 1994; 25: 563-8.
19. Hake R, Vorreuther R, Borchmann P et al. Monoklonale Antikorper (MIB 1, PC10, 486p & p53) als prognostische Parameter beim rezidivierenden urothelialen Karzinom der Harnblase. Ver Deutsch Gesell Pathol 1993; 77: 236-40.
20. Hall PA. Assessment of cell proliferation markers with particular emphasis on Ki-67 and PCNA. Dako monograph, 1993.
21. Delahunt B, Bethwaite, PB, Thornton A, Ribas JL. Proliferation kinetics of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome. Cancer 1995; 75: 2714-9.
22. Wagner U, Sauter G, Moch H et al. Patterns of p53, erb-2 and EGF-r expression in premalignant lesions of the urinary bladder. Hum Pathol 1995; 26: 970-8.